1. Home
  2. MAGN vs BNTC Comparison

MAGN vs BNTC Comparison

Compare MAGN & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnera Corporation

MAGN

Magnera Corporation

HOLD

Current Price

$12.19

Market Cap

430.0M

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$12.30

Market Cap

411.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAGN
BNTC
Founded
1864
1995
Country
United States
United States
Employees
8500
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
430.0M
411.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MAGN
BNTC
Price
$12.19
$12.30
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$12.00
$27.67
AVG Volume (30 Days)
324.9K
98.3K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.94
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.37
N/A
Revenue Next Year
$3.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.82
$9.85
52 Week High
$15.52
$17.15

Technical Indicators

Market Signals
Indicator
MAGN
BNTC
Relative Strength Index (RSI) 67.97 51.16
Support Level $10.15 $11.39
Resistance Level $15.24 $13.27
Average True Range (ATR) 0.63 0.67
MACD 0.21 -0.09
Stochastic Oscillator 72.17 34.51

Price Performance

Historical Comparison
MAGN
BNTC

About MAGN Magnera Corporation

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: